lower target price estim
lower ep estim
downward revis base lower interest rate pressur net
invest incom japan increas proport
usd-denomin invest higher claim due limit
mortal exposur april mortal analysi estim higher after-
tax life claim see increas claim product offer hospit benefit
 japan short-term disabl acquisit zurich
group benefit busi expect reduc ep
lower expect share repurchas partial off-set lower share price estim
excess capit billion book valu ex aoci
includ excess capit japan subsidiari thu may reduc share
buyback materi follow potenti temporari suspens pleas see
march capit sensit analysi detail factor partial
off-set stronger yen yen/dollar ratio end
compar end estim boost ep
reduc ep outlook base
modestli higher expect claim impact lower interest rate partial off-set
appreci yen dollar
lower target price reiter neutral rate
target price base price-to-book roe/co analysi risk includ currenc fluctuat
lower interest rate credit loss higher claim due
valuat metric
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
revenu fee
benefit expens
dac voba
total liabil equiti
earn contribut segment
profit valuat
price
provid supplement health life insur japan
repres earn includ gener
medic disabl accid critic care cancer insur
blue-ski valuat includ stronger yen
yield bp would increas net invest incom
reduc recent year due persist low interest rate environ
japan unit state
grey-ski valuat assum decreas yen/usd
bp lower interest rate japan unit state
produc grey-ski scenario
 close
compani mention price
andrew kligerman certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
